Unnatural Products

Private

Developing orally-delivered macrocyclic peptide therapeutics to address previously undruggable targets. Platform combines parallel experimentation and machine learning, with a Novartis licensing deal worth up to $1.7B in milestones.

Founders Scott Lokey

CEO Scott Lokey

Company

Founded

2020

Headquarters

Santa Cruz, United States

Financials

Total Funding

$62M

Sectors

Biotech

www.unnaturalproducts.com

Funding History

2 rounds

Series B Mar 16, 2026

$45M

The Venture Collective (Lead) argenx Droia Ventures Merck Global Health Innovation Fund ARTIS Ventures First Spark Ventures

Series A Jan 1, 2023

$17M

ARTIS Ventures (Lead) First Spark Ventures

Funding data is compiled from multiple independent sources including company announcements, press coverage, and regulatory filings. While we strive for accuracy, amounts and dates may reflect reported figures at time of announcement.